GLP1 & CKD

from Kidney Commute · host kidneycommute

In this episode of the Kidney Commute podcast, panelists delve into the role of glucagon-like peptide-1 (GLP-1) receptor agonists in chronic kidney disease. The discussion explores the mechanisms of GLP-1 receptor agonists, their benefits in managing both kidney disease and related comorbidities like diabetes and cardiovascular disease, and the latest evidence supporting their use. Panelists also address practical challenges faced by both patients and providers. Click here to claim CE Credit.

Episode metadata supplied by the publisher feed · Published Sep 6, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

GLP1 & CKD

0:00 24:56

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Kidney Commute?

This episode is 24 minutes long.

When was this Kidney Commute episode published?

This episode was published on September 6, 2024.

Can I download this Kidney Commute episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!